galactose has been researched along with Cirrhosis, Liver in 190 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 132 (69.47) | 18.7374 |
| 1990's | 30 (15.79) | 18.2507 |
| 2000's | 9 (4.74) | 29.6817 |
| 2010's | 12 (6.32) | 24.3611 |
| 2020's | 7 (3.68) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, J; Damgaard Sandahl, T; Grønbæk, H; Lund Laursen, T; Munk, DE; Ott, P; Vilstrup, H | 1 |
| Liu, JY; Liu, XY; Piao, JS; Piao, MG; Wu, ZC | 1 |
| Beyoğlu, D; Huang, P; Idle, JR; Popov, YV; Skelton-Badlani, D; Zong, C | 1 |
| Cheng, X; Cheng, Z; Li, C; Li, F; Nie, G; Qi, F; Sun, J; Wu, Z; Zhao, Y | 1 |
| Abdullahi, IN; Abramikas, Z; Agliani, G; Ahangar, N; Ahmed, AR; Aidietis, A; Aiying, W; Alabi, A; Álvarez, K; Anderson, L; André, MR; Araújo-Júnior, JX; Arqué, E; Asakereh, A; Audzijoniene, D; Azer, MK; Bacevicius, J; Badaras, I; Bagaev, A; Bailly, C; Bakky, MAH; Baojun, Y; Baran, E; Barbosa, RFS; Barzon, L; Basit, A; Basler, E; Bassi, ÊJ; Basyte-Bacevice, V; Bielak, K; Bileisiene, N; Birczyński, A; Blom, R; Boesen, L; Boucoiran, I; Bouwknegt, M; Brandão, JA; Bravo, F; Brien, MÈ; Bruijning-Verhagen, PCJL; Butkuviene, M; Cai, DC; Cai, X; Camani, PH; Cao, S; Carey, IM; Chakravarthy, C; Chandler, F; Chang, SW; Chen, C; Chen, H; Chen, J; Chen, S; Chen, T; Chen, W; Chen, X; Chen, Y; Chen, YT; Chen, Z; Chou, WC; Choudhary, S; Chu, W; Chung, H; Cilin, W; Coelho, GL; Collet, C; Cools, C; Cooper, A; Corkhill, CL; Cornelis, JT; Costa, CACB; Currie, A; da S Ferreira, G; da Silva, DJ; Dai, Y; Dal Soglio, D; de Bellegarde de Saint Lary, C; de Bruin, E; de Los Ríos, JD; Deenadayalan, B; Del Río, M; Ding, HT; Dong, GH; Dong, K; Dorożyński, P; Drössler, L; Dvinelis, E; Ebrahimi, M; Fan, W; Fan, Z; Feng, Y; Ferreira, RR; Fortunov, RM; Freitas, JD; Gan, J; Gao, J; García-Depraect, O; Ge, Q; Giglia, G; Giguère, F; Girard, S; Godfrey, J; Gokyar, S; Gonçalves, LR; Gong, S; Gouder, T; Graf, C; Grinter, S; Gröne, A; Gudauskas, M; Guo, T; Guo, Y; Guryanova, OA; Hagan, JL; Hamamoto, K; Hansen, AE; Hasnan, NSN; He, X; He, YL; Hessel, V; Heym, M; Hindle, S; Hogan, CA; Hogema, BM; Hu, J; Hu, P; Huang, M; Huang, S; Huang, X; Huang, Y; Hyatt, NC; Jacobson, C; Jakaite, R; Jasiunas, E; Jeffres, MN; Ji, CF; Jia, K; Jia, Z; Jian, T; Jiang, L; Jiang, W; Jiang, X; Jiang, Y; Jiang, Z; Jiao, Y; Jin, JH; Jing, T; Johnson, L; Ju, L; Jukna, E; Juknevicius, V; Jung, J; Kakkar, F; Kalpana, ML; Kamankesh, M; Kan, E; Kan, N; Karuzas, A; Kasbergen, LMR; Kassim, MB; Ke, Z; Kettles, K; Khan, OA; Khattab, M; Khoee, S; Kiel, E; Kik, M; Kiseliute, M; Kline, JP; Koonce, RC; Koopmans, MPG; Korboulewsky, N; Krause, A; Kulinowski, P; Kundelis, R; La, DD; Lai, HT; Lai, Q; Lange, U; Lasheen, ESR; Latorre-Fernandez, J; Lei, M; Lesperance, J; Li, DC; Li, H; Li, HY; Li, JF; Li, K; Li, L; Li, M; Li, N; Li, P; Li, Q; Li, S; Li, T; Li, WN; Li, X; Li, Y; Li, Z; Liang, C; Liang, H; Liang, M; Liao, H; Liao, Y; Liu, C; Liu, H; Liu, K; Liu, X; Liu, XQ; Liu, Y; Löf, M; Long, Z; Lozano, C; Lu, X; Lühken, R; Luo, H; Lv, T; Lyu, CY; Lyu, T; Løgager, V; Ma, C; Ma, H; Ma, SJ; Machado, RZ; Mafakheri, F; Mahawar, K; Maheshkumar, K; Manga, P; Mao, XR; Marciano, JS; Marinskiene, J; Marozas, V; McGlone, ER; Meester, M; Mella, A; Meng, X; Meng, Z; Meulenbroek, CB; Min, QQ; Mohamed, MA; Molina, D; Monti, G; Mortimer, RJG; Mottram, LM; Mpanya, D; Müller, A; Muñoz, R; Muys, B; Myczko, Ł; Møller, JM; Najib, Y; Navarro, M; Nel, S; Neveln, NK; Nguyen, DD; Nguyen, PHT; Ni, S; Niu, Y; Nomie, K; Nordin, NA; Norvell, MR; Nothdurft, A; Okui, MA; Okui, N; Osei, R; Osorio-Tejada, JL; Ouyang, D; Pach, M; Pan, B; Pan, G; Paredes, R; Párraga-Niño, N; Passos, GFS; Patil, RS; Pedro-Botet, ML; Pelletier, F; Petrylaite, M; Pham, KTT; Pilkiene, A; Ponette, Q; Popov, Y; Porter, M; Postovalova, E; Pretzsch, H; Pring, C; Pu, M; Puigoriol, E; Qi, B; Qi, H; Qi, Y; Qiao, T; Qin, S; Qiu, Y; Qiu, Z; Quero, S; Ramsay, M; Rao, J; Rashwan, MA; Rathod, DK; Rebrov, E; Regueira-Marcos, L; Ren, Y; Reynaga, E; Ricco, MH; Rojas, L; Romero, A; Rosa, DS; Ruiz-Peinado, R; Sang, YQ; Sauer, FG; Schmidt-Chanasit, J; Sepúlveda-García, P; Serra-Pladevall, J; Serras-Pujol, M; Shaki, F; Shao, X; Shen, L; Sheng, Z; Shi, R; Shi, YF; Shou, Q; Shu, L; Shuhua, L; Sikkema, RS; Silva-Júnior, EFD; Simon, C; Small, PK; Smith, SM; Sokas, D; Song, Y; Soudeyns, H; Souza, AG; Souza, BG; Staigyte, J; Stankeviciute, G; Stegeman, A; Stennett, MC; Stollberger, R; Sun, SK; Sun, SP; Sun-Waterhouse, D; Sundgren, NC; Sung, E; Sunseri, N; Suryadevara, SS; Tan, X; Tang, Y; Tao, F; Taparauskaite, N; Ten Bosch, Q; Titeux, H; Tobias, TJ; Tomar, S; Torres, C; Tran, DL; Tran, NT; Trudel, MJ; Tsabedze, N; Tumuluru, S; Um, MJ; Van Bui, C; Van den Brand, JMA; van den Broek, J; van der Jeugd, H; van der Klis, FRM; van der Poel, WHM; van Mastrigt, T; Varlamova, A; Venkataraman, G; Venkateswaran, ST; Venugopal, V; Vilamala, A; Vilela, GG; Visser, LG; Wagdargi, SS; Wan Ishak, WNR; Wan, S; Wang, B; Wang, DJ; Wang, H; Wang, J; Wang, JT; Wang, JY; Wang, L; Wang, LM; Wang, S; Wang, W; Wang, X; Wang, XH; Wang, Y; Wang, Z; Webster, GD; Wei, C; Wei, T; Welbourn, R; Wells, Q; Wiatrowska, B; Wong, M; Wongsomboon, V; Wu, B; Wu, Q; Wu, S; Wu, T; Wu, Y; Wu, Z; Xiang, P; Xiang, Z; Xiao, D; Xiao, L; Xiao, T; Xie, J; Xie, S; Xie, Z; Xu, B; Xu, D; Xu, H; Xue, XS; Yang, J; Yang, Y; Yao, R; Ye, L; Ye, N; Yin, X; You, L; Yu, H; Yu, J; Yun, T; Yuxuan, H; Zaaijer, HL; Zamani, E; Zang, X; Zarazaga, M; Zarembaite, G; Zaroogian, Z; Zarubin, D; Zeeshan, M; Zeng, H; Zeng, S; Zeng, XW; Zha, J; Zha, Y; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, J; Zhang, JZ; Zhang, L; Zhang, M; Zhang, R; Zhang, T; Zhang, X; Zhang, XY; Zhang, Y; Zhang, Z; Zhao, C; Zhao, P; Zhao, R; Zhao, WP; Zhao, Y; Zhao, Z; Zheng, E; Zheng, F; Zheng, H; Zhou, C; Zhou, D; Zhou, Y; Zhu, AX; Zhu, B; Zhu, J; Zhuang, H | 1 |
| Buzina, W; Hoenigl, M; Koidl, C; Krause, R; Prattes, J; Reischies, F; Valentin, T; Zollner-Schwetz, I | 1 |
| Alberton, V; Bott, C; Cassol, CA; Malvar, A; Nadasdy, GM; Nadasdy, T; Nagaraja, HN; Rovin, BH; Satoskar, AA | 1 |
| Chang, WY; Chen, CL; Chen, JT; Kao, HW; Lin, WJ; Wang, HE; Wang, SJ | 1 |
| Chou, H; Fiel, MI; Friedman, SL; Hong, F; Klyosov, A; Traber, PG; Zomer, E | 1 |
| BRODIE, JL | 1 |
| Bibby, BM; Frisch, K; Keiding, S; Mikkelsen, KS; Sørensen, M; Villadsen, GE | 1 |
| Chang, TT; Chen, SH; Cheng, PN; Chien, RN; Ho, CH; Li, IC; Liu, CK; Liu, JH; Liu, WC; Su, CS; Tsai, HW; Wu, IC; Wu, SL | 1 |
| Goldman, R; Koomen, J; Sanda, M; Wu, J; Yuan, W | 1 |
| Andersen, PK; Jepsen, P; Keiding, S; Ott, P; Tygstrup, N; Vilstrup, H | 1 |
| Blomme, B; Callewaert, N; Colle, I; Van Steenkiste, C; Van Vlierberghe, H; Vanhuysse, J | 1 |
| Aagaard, NK; Andersen, NH; Holland-Fischer, P; Kazankov, K; Sloth, E; Torp, P; Vilstrup, H | 1 |
| de Knegt, RJ; Francke, J; Hansen, BE; Kuipers, EJ; Stibbe, KJ; van Vuuren, AJ; Verveer, C; Zondervan, PE | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Chang, WY; Chen, CL; Chen, JT; Kao, HW; Lin, WJ; Liu, RS; Wang, HE | 1 |
| Behrmann, C; Fleig, WE; Kleber, G; Meiss, F; Steudel, N; Sziegoleit, U; Zipprich, A | 1 |
| FOX, EG; FYFE, WM; MOLLISON, AW | 1 |
| CRAIG, JM; GELLIS, SS; HSIA, DY | 1 |
| TYGSTRUP, N | 2 |
| KOPECKY, A | 1 |
| ROSCHLAU, G | 1 |
| Núñez, M; Santidrián, S; Urdaneta, E | 1 |
| MASON, HH; STRONG, PS; TOWNSEND, EH | 1 |
| ALSLEV, J | 1 |
| Castilla, A; Castilla-Cortázar, I; Díaz-Casares, A; Díaz-Sánchez, M; García, M; González-Barón, S; Pardo, J; Pascual, M; Puche, JE; Urdaneta, E; Varela-Nieto, I; Vivas, B | 1 |
| Akaike, J; Karino, Y; Kuwata, Y; Ohmura, T; Sato, T; Suga, T; Toyota, J; Yamazaki, K | 1 |
| Borro, P; Botta, F; Cotellessa, T; Fasoli, A; Fumagalli, A; Giannini, EG; Malfatti, F; Milazzo, S; Polegato, S; Risso, D; Testa, E; Testa, R | 1 |
| Addario, L; Ascione, A; De Luca, M; Di Costanzo, GG; Galeota Lanza, A; Giannelli, E; Lampasi, F; Macr, M; Picciotto, FP; Scaglione, G; Tartaglione, MT; Tritto, G; Utech, W | 1 |
| de Verdier, CH; Hjelm, M; Tengström, B; Werner, I | 1 |
| Fassati, M; Fassati, P | 1 |
| Lenler-Petersen, P; Søgård, H; Thestrup-Pedersen, K; Zachariae, H | 1 |
| Hansen, BA; Keiding, S; Lund, J; Mengel, H | 1 |
| Henderson, JM; Kutner, MH; Millikan, WJ; Warren, WD; Wright-Bacon, L | 1 |
| Huguenin, P; Preisig, R; Renner, E; Wahländer, A; Wietholtz, H | 1 |
| Lindskov, J; Ranek, L; Tygstrup, N; Winkler, K | 2 |
| Hanna, SS; Henderson, JM | 1 |
| Gerok, W; Herz, R; Hiss, W; Rössle, M | 1 |
| Bain, RP; Henderson, JM; Kutner, MH | 1 |
| Lindskov, J | 3 |
| Angiolini, A; Bianchi, FB; Dondi, C; Marchesini, G; Pisi, E; Zoli, M | 1 |
| Fales, FW; Henderson, JM | 1 |
| Arnáu Silla, A; Cervera Montes, M; Colomer Terres, J; Perez Modesto, F; Peris Aguirre, L; Romar Mico, A; Tormo Calandin, C | 1 |
| Iakhontova, OI; Reĭskanen, AV | 1 |
| Bianchi, L; Dällenbach, A; Reichen, J; Renner, EL; Schmid, M; Solioz, M | 1 |
| Imaoka, T; Kitamra, T; Kitamura, S; Ooura, Y; Tanaka, S; Yamamoto, K; Yoshioka, F | 1 |
| Chang, CL; Hu, OY; Tang, HS | 1 |
| Chen, TC; Curry, SH; Hu, OY; Sheeng, TY; Tang, HS | 1 |
| Henriksen, JH; Tygstrup, N; Winkler, K | 1 |
| Hanafusa, T; Higashi, T; Kajitani, M; Kurokawa, T; Ogawa, H; Ohshima, K; Tsuboi, H; Umeda, M; Yumoto, E; Yumoto, Y | 1 |
| Deng, JF; Huang, YS; Lee, SD; Lin, YF; Lo, KJ; Lu, RH; Wang, YJ; Wu, JC | 1 |
| Gross, V; Haag, K; Neis, W; Schölmerich, J; Treher, E; Wiegand, U | 1 |
| Anderson, SE; Ballmer, PE; Garlick, PJ; McNurlan, MA; Reichen, J; Sterchi, AB | 1 |
| Bianchi, G; Bugianesi, E; Marchesini, G; Ronchi, M; Tangerman, A | 1 |
| Ambiru, S; Ito, H; Kaiho, T; Miyazaki, M; Nakajima, N; Ohtsuka, M; Sasada, K; Shimizu, H; Shimizu, Y; Shiobara, M; Togawa, A; Yoshidome, H; Yoshioka, S | 1 |
| Almasio, P; Ascione, A; Bernardi, M; Borroni, G; Budillon, G; Capuano, G; Marchesini, G; Marenco, G; Molino, G; Moser, P; Muraca, M; Rossaro, L; Salerno, F; Sangiovanni, A; Solinas, A | 1 |
| Bellon, S; Bianco, S; Bolognesi, M; Chiesura-Corona, M; Enzo, E; Feltrin, G; Gatta, A; Merkel, C; Miotto, D; Savastano, S | 1 |
| Bianchi, G; Brizi, M; Fabbri, A; Marchesini, G; Zoli, M | 1 |
| Fleig, WE; Hahn, EG; Link, I; Lotterer, E; Wensing, G | 1 |
| Bar, F; Battista, S; Cappello, N; Garello, E; Molino, G; Niro, GA; Rizzetto, M | 1 |
| Berger, F; Minaire, Y; Mion, F; Rousseau, M; Scoazec, JY | 1 |
| Chioléro, R; Gillet, M; Jéquier, E; Schneiter, P; Tappy, L | 1 |
| Bernardi, M; Caraceni, P; Cavallari, A; De Notariis, S; Domenicali, M; Grazi, GL; Mainquà, P; Mazziotti, A; Santese, G; Sica, G; Trevisani, F; Zacà, F | 1 |
| Hahn, EG; Heinz, R; Herold, C; Radespiel-Tröger, M; Schneider, HT; Schuppan, D | 1 |
| Borro, P; Botta, F; Chiarbonello, B; Fasoli, A; Fumagalli, A; Giannini, E; Malfatti, F; Polegato, S; Romagnoli, P; Savarino, V; Testa, E; Testa, R | 1 |
| Kardel, T; Stigsby, B | 1 |
| Anttinen, H; Kivirikko, KI; Kuutti-Savolainen, ER; Miettinen, TA | 1 |
| Bircher, J; Colombo, JP | 1 |
| Teien, AN | 1 |
| Caspary, WF; Schäffer, J | 1 |
| Freides, D; Jenko, P; Rikkers, L; Rudman, D | 1 |
| Jagenburg, R; Olsson, R; Regårdh, CG; Rodjer, S | 1 |
| Nakamura, S; Sato, T; Takezawa, Y; Yoshida, G | 1 |
| Jörgensen, BJ; Kardel, T; Rasmussen, SN | 1 |
| Kardel, T; Nörby Rasmussen, S; Ramsöe, K | 1 |
| Gade, S; Hugod, C; Krasilnikoff, A; Kristensen, HP | 1 |
| DaCosta, H; Merchant, S; Shreeve, WW | 1 |
| McInteer, BB; Ott, DG; Shoop, JD; Shreeve, WW | 1 |
| Hu, OY; Tang, HS | 1 |
| Bianchi, G; Bugianesi, E; Fabbri, A; Marchesini, G; Marchi, E; Pisi, E; Zoli, M | 1 |
| Budillon, G; Citarella, C; Del Vecchio Blanco, C; Loguercio, C; Nardone, G; Sicolo, P | 1 |
| Amodio, P; Bianco, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Becker, H; Ebener, T; Groteguth, R; Niederau, C; Stremmel, W; Strohmeyer, G; Wojdat, R; Zoedler, M | 1 |
| Bircher, J; Gressner, AM; Grobe, E; Kropf, J; Lotterer, E; von Knebel, D | 1 |
| Angeli, P; Bolognesi, M; Gatta, A; Iervese, T; Marchesini, G; Merkel, C; Ruol, A; Zoli, M | 1 |
| Bianchi, G; Bonazzi, C; Cordiani, MR; Iervese, T; Labate, AM; Marchesini, G; Pisi, E; Zoli, M | 1 |
| Bianchi, G; De Mitri, MS; Fabbri, A; Marchesini, G; Pisi, E; Vilstrup, H; Zoli, M | 1 |
| Hayakawa, K; Marotta, F; Morello, P; Ono, K; Ragno, F; Salamanca, S; Sasaki, M; Vitale, G | 1 |
| Bianchi, GP; Bugianesi, E; Fabbri, A; Marchesini, G; Marchi, E; Pisi, E; Zoli, M | 1 |
| Beuers, U; Wahlländer, A | 1 |
| Albers, I; Bircher, J; Creutzfeldt, W; Hartmann, H | 1 |
| Morgan, DV; Smallwood, RA | 1 |
| Birardi, A; Buzzelli, G; Chiarantini, E; Meacci, E; Smorlesi, C | 1 |
| Birardi, A; Buzzelli, G; Chiarantini, E; Gentilini, P; Meacci, E; Smorlesi, C | 1 |
| Buzzelli, G; Cotrozzi, G; Guazzelli, R; Relli, P; Strazzulla, G | 1 |
| Buzzelli, G; Cotrozzi, G; Guazzelli, R; Relli, P; Strazzula, G | 1 |
| Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C | 1 |
| Bianchi, GP; Capelli, M; Forlani, G; Marchesini, G; Patrono, D; Pisi, E; Rusticali, AG; Vannini, P; Zoli, M | 1 |
| Beppu, T; Hanano, M; Idezuki, Y; Iga, T; Kawasaki, S; Sanjo, K; Sugiura, M; Sugiyama, Y | 1 |
| Brooks, WS; Galambos, JT; Henderson, JM; Kutner, MH; Millikan, WJ; Riepe, SP; Salam, AA; Warren, WD | 1 |
| Caregaro, L; Gatta, A; Merkel, C; Milani, L; Rondana, M | 1 |
| Buzzelli, G; Cotrozzi, G; Lupi, R; Meacci, E; Relli, P; Strazzulla, G | 1 |
| Brocchi, A; Buzzelli, G; Cotrozzi, G; Meacci, E; Relli, P; Smorlesi, C; Strazzulla, G | 1 |
| Dalhoff, K; Gammans, RE; Garred, P; Mayol, RF; Pfeffer, M; Placchi, M; Poulsen, HE | 1 |
| Hanna, SS; Maheshwari, Y | 1 |
| Tiribelli, C; Vallini, R; Zaramella, MG | 1 |
| Budillon, G; Carrella, M; Colombi, A; Coltorti, M; Di Simone, A; Lucchelli, PE; Oriani, GA | 1 |
| Feist, D; Rossner, JA | 1 |
| Mincev, M | 2 |
| Dal Palù, C; Spandri, P; Zuin, R | 1 |
| Smetana, HF | 1 |
| Amagase, H; Arimura, K; Hirayama, C; Kawasaki, H | 1 |
| Glew, RH; Iammarino, RM; Kuhlenschmidt, MS; Peters, SP; Turco, SJ; Yunis, EJ | 1 |
| Arfeen, N; Barth, V; Müting, D; Ordnung, W; Reikowski, J | 1 |
| Hoffrichter, E; Maaz, E | 1 |
| Eisenburg, J; Grunst, J; Krumpoch, B; Magerl, W; Munte, A; Schauer, S; Schmidt, S; Weinzierl, M | 1 |
| Ben Amar, A; el-Guedry, H; Hecht, Y; Nakache, JP; Salmon, D; Touboul, JP | 1 |
| Beretta, R; Cassi, E; Colombo, A; Cova, L; Ezechieli, S; Malacco, E; Massarotti, G; Pagani, C; Sala, E | 1 |
| Ito, M; Kato, K; Kikuchi, S; Oya, T; Shiga, O | 1 |
| Bircher, J; Blankart, R; Häcki, W; Halpern, A; Laissue, J; Preisig, R | 1 |
| Benamar, A; el-Guedri, H; Hecht, Y; Nakache, JP; Salmon, D; Touboul, JP | 1 |
| Kardel, T; Rasmussen, SN | 1 |
| Maaz, E | 1 |
| Kesäniemi, YA; Kurppa, KO; Salaspuro, MP | 1 |
| Kesäniemi, YA; Salaspuro, MP | 1 |
| Bach-Mortensen, N; Lindskov, J | 1 |
| Kardel, T | 1 |
| Hultman, E; Nilsson, LH | 2 |
| Kardel, T; Nielsen, VK | 1 |
| Andreasen, PB; Hvidberg, EF; Ranek, L | 1 |
| Brown, H; Goransky, L; McDermott, WV; Trey, C | 1 |
| Hennecke, A; König, KJ; Südhof, H | 1 |
| Bircher, J; Halpern, A; Preisig, R; Scholl, E; Stirnemann, H; Strebel, H; Tauber, J; Weber, M | 1 |
| Curtis, KJ; Kim, YS; Perdomo, J; Whitehead, JS | 1 |
| Kuntz, E | 1 |
| Aikawa, T; Iida, H; Nakamura, S; Nakamura, T; Onodera, A; Suzuki, O | 1 |
| Ege, P; Jacobsen, M | 1 |
| Kato, K; Kikuchi, S; Shiga, O | 1 |
| Akioka, H; Hayashi, T; Kamono, K; Okumi, T; Yamaguchi, H | 1 |
| Kierulf, P; Myren, J | 1 |
| Berger, R; Broyer, M | 1 |
| Tengström, B | 2 |
| Grimmel, K; Rommel, K | 2 |
| Gitzelmann, R | 1 |
| Brown, H; McDermott, WV; Trey, C | 2 |
| Enache, C; Galea, G; Niţu, V; Sdrobici, D | 1 |
| Bircher, J; Blankart, R; Bucher, H; Fuchs, WA; Halpern, A; Preisig, R; Rösler, H; Tauber, J | 1 |
| Järnerot, G | 2 |
| Rorsman, G; Sulg, I | 1 |
| Bircher, J; Heri, M | 1 |
| Voegeli, E | 1 |
| Rommel, K; Török, M | 1 |
| Joussipova, NA; Rosenfeld, EL | 1 |
| Förster, H; Haslbeck, M; Mehnert, H | 1 |
| Albot, G; Boisson, J; Chaput, JC; Foulon, D; Gruyer, M; Leluan, G; Liguory, C; Lunel, J; Samdja, M; Veyne, S | 1 |
| Albot, G; Boisson, J; Chaput, JC; Foulon, D; Gruyer, M; Lévy, JC; Lunel, J; Smadja, M; Veyne, S | 1 |
| Gershberg, H; Hernandez, A; Zorrilla, E | 1 |
| Dal Palù, C; Spandri, P | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| GUNTHER, PG; OSWALD, H | 1 |
| FUKUTA, Y | 1 |
| Koshy, A; Walia, BN | 1 |
| Gupta, PP; Raturi, BM; Raturi, M; Saxena, S; Sharma, U | 1 |
| Ivanov, AI; Radchenko, VG | 1 |
| Fedianin, IuP | 1 |
| Cornillot, P; Fabia, F; Gattegno, L | 1 |
| Ravnskov, U; Svensson, L | 1 |
| Froehlich, AL | 1 |
| Endo, M; Matsushiro, T; Nemoto, T; Yosizawa, Z | 1 |
| Balesnaia, AN; Baran, VM; Iusipova, NA | 1 |
| Mester, L; Soria, J; Szabados, L | 1 |
| Fehér, J; Jakab, L; Józsa, L; Papp, G | 1 |
| Frotz, H; Gheorghiu, T; Klein, HJ | 1 |
| Beck, K; Queisser, W; Wolf, HP | 1 |
| Geffroy, PY; Geffroy, Y; Segrestin, M | 1 |
| Kerschbaumer, FW | 1 |
4 review(s) available for galactose and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
[Liver tests and tests of liver function (author's transl)].
Topics: Aminopyrine; Cholestasis; Clinical Enzyme Tests; Galactose; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Neoplasm Metastasis; Sulfobromophthalein | 1978 |
Cirrhosis of the liver: principles of classification, histogenesis, and pathogenesis.
Topics: Adult; Aged; Animals; Female; Galactose; Haplorhini; Hemochromatosis; Humans; Inclusion Bodies; Infant; Infant, Newborn; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Neoplasms; Macaca; Male; Metabolism, Inborn Errors; Nutrition Disorders; Portal System | 1972 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
13 trial(s) available for galactose and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Topics: Antibodies, Neoplasm; Carcinoma, Hepatocellular; Female; Galactose; Glycosylation; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mass Spectrometry; Middle Aged | 2015 |
Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.
Topics: Adult; Aged; Blood Flow Velocity; Carcinoma, Hepatocellular; Chronic Disease; Contrast Media; Female; Galactose; Hepatitis; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polysaccharides; Ultrasonography, Doppler, Color | 1995 |
Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method.
Topics: Adult; Blood Proteins; Galactose; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Promazine; Protein Binding | 1995 |
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Galactose; Hepatitis; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin Time; Serum Albumin | 1993 |
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio d
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Galactose; Humans; Italy; Liver; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis | 1996 |
Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations.
Topics: Adolescent; Adult; Aged; Butyrylcholinesterase; Child; Female; Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Sorbitol; Survival Analysis | 1999 |
Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. II. Galactosylhydroxylysyl glucosyltransferase.
Topics: Adult; Clinical Trials as Topic; Collagen; Female; Galactose; Glucosyltransferases; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1979 |
Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
Topics: Adult; Aged; Female; Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Terlipressin | 1992 |
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial.
Topics: Acute Disease; Biopsy, Needle; Esophageal and Gastric Varices; Esophagoscopy; Follow-Up Studies; Galactose; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Portasystemic Shunt, Surgical; Prospective Studies; Random Allocation; Recurrence; Sclerosing Solutions; Splenorenal Shunt, Surgical; Time Factors | 1986 |
Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration.
Topics: Animals; Brain Diseases; Carbohydrate Metabolism; Clinical Trials as Topic; Colon; Dogs; Feces; Fructose; Galactose; Glucose; Glucose Tolerance Test; Humans; Hydrogen-Ion Concentration; Insulin; Iodine Isotopes; Liver; Liver Cirrhosis; Liver Diseases; Portacaval Shunt, Surgical | 1970 |
Lactulose treatment of hepatic encephalopathy in outpatients.
Topics: Adolescent; Aged; Alcoholism; Ambulatory Care; Ammonia; Brain Diseases; Colon; Diet Therapy; Dietary Proteins; Electroencephalography; Female; Fructose; Galactose; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis; Male; Middle Aged; Nitrogen; Portacaval Shunt, Surgical; Sorbitol | 1971 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
175 other study(ies) available for galactose and Cirrhosis, Liver
| Article | Year |
|---|---|
The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease.
Topics: Galactose; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Function Tests | 2022 |
Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
Topics: Animals; Asialoglycoprotein Receptor; Betulinic Acid; Chitosan; Drug Carriers; Galactose; Liver Cirrhosis; Mice; Nanoparticles; Pentacyclic Triterpenes | 2022 |
Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis.
Topics: Aldehyde Reductase; Animals; Ascorbic Acid; Collagen; Diet, High-Fat; Fructose; Galactose; Glucose; Glucuronates; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL | 2023 |
The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression.
Topics: Animals; Apoptosis; Bilirubin; Galactose; Liver; Liver Cirrhosis; Mice; Nanomedicine; Perfusion; Polyethylene Glycols; Reactive Oxygen Species | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acrylamides; Actins; Adult; African People; Air Pollutants; Alanine Transaminase; Androgens; Animals; Anti-Bacterial Agents; Antibodies, Bispecific; Antiviral Agents; Arteries; Bioelectric Energy Sources; Bioreactors; Brain; Carbon Dioxide; Carbon Tetrachloride; Cardiomyopathy, Dilated; Cerebral Cortex; Cerebrovascular Circulation; Charcoal; Chemical and Drug Induced Liver Injury; Chikungunya Fever; Chikungunya virus; Chitosan; Chlorocebus aethiops; Claudins; Contrast Media; Cynodon; Cytokines; Desmin; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Ecosystem; Elasticity Imaging Techniques; Escherichia coli; Fatty Acids, Volatile; Female; Fermentation; Filtration; Food; Gadolinium; Galactose; Gastrointestinal Microbiome; Gene Expression; Gene Expression Regulation, Leukemic; Gracilaria; Heart Failure; HeLa Cells; Hematopoietic Stem Cells; Hepatic Stellate Cells; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatocytes; HIV; HIV Infections; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxy Acids; Hydroxyl Radical; Imaging, Three-Dimensional; Immunity; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-33; Interleukin-4; Keratin-18; Kinetics; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Lipidomics; Lipids; Liver; Liver Cirrhosis; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microalgae; Middle Aged; Mutation; Nanoparticles; Nitrogen; Nuclear Proteins; Oxidation-Reduction; Particulate Matter; Phylogeny; Phytoplankton; Placenta; Polysaccharides; Polystyrenes; Polyvinyl Alcohol; Predictive Value of Tests; Pregnancy; Prognosis; Programmed Cell Death 1 Receptor; Prospective Studies; Prostate; Prostatic Neoplasms; Rain; Receptors, Immunologic; Recombinant Proteins; Refuse Disposal; Reproducibility of Results; Restaurants; Retrospective Studies; Reverse Transcriptase Inhibitors; Sand; Seawater; Sheep; Sheep, Domestic; Sodium Hydroxide; Spin Labels; Stomach Neoplasms; Stroke Volume; Sulfates; Tensile Strength; Th1 Cells; Th17 Cells; Th2 Cells; Transcriptome; Tumor Microenvironment; Ultraviolet Rays; Ventricular Function, Left; Vero Cells; Virus Replication; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; Water Supply; Wetlands; Xylitol; Xylose | 2023 |
Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study.
Topics: Aged; Aspergillosis; Cohort Studies; Female; Galactose; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Mannans; Middle Aged; Prevalence; Prospective Studies; Sensitivity and Specificity | 2017 |
Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Diagnosis, Differential; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Liver Cirrhosis; Lupus Nephritis; Male; Middle Aged; Psoriasis; Retrospective Studies; Staining and Labeling; Young Adult | 2020 |
Synthesis and biological evaluation of technetium-99m labeled galactose derivatives as potential asialoglycoprotein receptor probes in a hepatic fibrosis mouse model.
Topics: Animals; Asialoglycoprotein Receptor; Disease Models, Animal; Galactose; Liver Cirrhosis; Mice; Radiopharmaceuticals; Technetium Compounds; Tomography, Emission-Computed, Single-Photon | 2013 |
Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line; Cell Proliferation; Fibrosis; Galactans; Galactose; Galectins; Humans; Liver Cirrhosis; Liver Diseases; Male; Mannans; Pectins; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Thioacetamide | 2013 |
[Galactosemia].
Topics: Child; Galactose; Galactosemias; Humans; Infant; Liver Cirrhosis; Malnutrition | 1952 |
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Topics: Adult; Aged; Algorithms; Data Interpretation, Statistical; Female; Fucose; Galactose; Humans; Linear Models; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Veins | 2014 |
Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy.
Topics: Antiviral Agents; Case-Control Studies; Cell Line, Tumor; DNA, Viral; Female; Galactose; Glycosylation; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulin G; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; U937 Cells | 2015 |
The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.
Topics: Cohort Studies; Denmark; Female; Follow-Up Studies; Galactose; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Registries; Regression Analysis; Retrospective Studies | 2009 |
Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Bilirubin; Carbohydrate Sequence; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Common Bile Duct; Female; Fucose; Galactose; Glycosylation; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Polysaccharides | 2010 |
Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.
Topics: Biopsy; Body Mass Index; Cardiomyopathies; Echocardiography, Doppler, Color; Galactose; Humans; Liver Cirrhosis; Regression Analysis; Ventricular Function, Left | 2011 |
Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
Topics: Acetamides; Adult; Aspartate Aminotransferases; Biomarkers; Blood Platelets; Breath Tests; Elasticity Imaging Techniques; False Negative Reactions; False Positive Reactions; Female; Galactose; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Linear Models; Liver; Liver Cirrhosis; Male; Middle Aged; ROC Curve | 2011 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
(18)F-FBHGal for asialoglycoprotein receptor imaging in a hepatic fibrosis mouse model.
Topics: Animals; Asialoglycoprotein Receptor; Benzamides; Disease Models, Animal; Fluorine Radioisotopes; Galactose; Half-Life; Hep G2 Cells; Humans; Liver Cirrhosis; Mice; Microscopy, Confocal; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2013 |
Functional significance of hepatic arterial flow reserve in patients with cirrhosis.
Topics: Adenosine; Adult; Blood Flow Velocity; Blood Volume; Coloring Agents; Female; Galactose; Hepatic Artery; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Male; Middle Aged; Pulse; Regional Blood Flow; Severity of Illness Index; Vasodilation | 2003 |
Galactose diabetes.
Topics: Diabetes Mellitus; Galactose; Humans; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Newborn, Diseases; Liver Cirrhosis | 1954 |
Cirrhosis of the liver in infants and children.
Topics: Bile Duct Diseases; Bile Ducts; Child; Disease; Galactose; Glycogen Storage Disease; Hemochromatosis; Hepatitis; Humans; Infant; Liver Cirrhosis; Pancreas; Pancreatic Diseases | 1955 |
THE GALACTOSE ELIMINATION CAPACITY IN CONTROL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS OF THE LIVER.
Topics: Biological Transport; Carbohydrate Metabolism; Galactose; Humans; Liver Cirrhosis; Liver Function Tests | 1964 |
THE GALACTOSE ELIMINATION CAPACITY IN RELATION TO CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH CIRRHOSIS.
Topics: Bilirubin; Blood Protein Electrophoresis; Carbohydrate Metabolism; Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Serum Albumin; Serum Globulins; Sulfobromophthalein; Thymol | 1964 |
[PAPER CHROMATOGRAPHY OF URINARY SUGARS].
Topics: Adolescent; Arabinose; Carbohydrates; Chromatography; Chromatography, Paper; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis; Fructose; Galactose; Galactosemias; Glucose; Glycosuria; Glycosuria, Renal; Hexoses; Humans; Liver Cirrhosis; Nephrosis; Sucrose; Urine; Xylose | 1964 |
[On liver cirrhosis in an infant with galactosemia].
Topics: Child; Galactose; Galactosemias; Humans; Infant; Liver Cirrhosis | 1962 |
Effect of insulin-like growth factor-I on nitrogen balance and intestinal galactose transport in rats with moderate liver cirrhosis.
Topics: Animals; Biological Transport; Body Weight; Feces; Galactose; Intercellular Signaling Peptides and Proteins; Intestinal Absorption; Jejunum; Liver; Liver Cirrhosis; Male; Nitrogen; Organ Size; Rats; Rats, Wistar; Recombinant Proteins | 2003 |
Galactosemia and its relation to Laennec's cirrhosis; review of the literature and presentation of six additional cases.
Topics: Galactose; Galactosemias; Humans; Liver Cirrhosis | 1951 |
[Comparative studies on intermediary galactose and dextrose metabolism in healthy and in patients with liver cirrhosis].
Topics: Carbohydrate Metabolism; Galactose; Glucose; Health; Humans; Liver Cirrhosis | 1952 |
Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I.
Topics: Amino Acids; Animals; Atrophy; Biological Transport; Carbon Tetrachloride; Galactose; Insulin-Like Growth Factor I; Jejunum; Liver Cirrhosis; Male; Microvilli; Rats; Rats, Wistar | 2004 |
Evaluation of arterial blood flow in esophageal varices via endoscopic color Doppler ultrasonography with a galactose-based contrast agent.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Collateral Circulation; Contrast Media; Diastole; Endosonography; Esophageal and Gastric Varices; Esophagus; Female; Galactose; Humans; Japan; Liver Cirrhosis; Male; Middle Aged; Pulsatile Flow; Regional Blood Flow; Systole; Ultrasonography, Doppler, Color | 2005 |
13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease.
Topics: Adult; Aged; Aminopyrine; Breath Tests; Female; Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Sensitivity and Specificity | 2005 |
Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
Topics: Adult; Disease Progression; Epidemiologic Methods; Female; Galactose; Hepatitis, Viral, Human; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prognosis; Severity of Illness Index | 2006 |
Intravenous galactose tolerance test with the use of an enzymatic method for the determination of galactose.
Topics: Alkaline Phosphatase; Galactose; Gallstones; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms | 1967 |
[Galactose test in the diagnosis of chronic liver diseases, particularly cirrhoses].
Topics: Galactose; Humans; Liver Cirrhosis; Liver Diseases | 1967 |
Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Topics: Administration, Oral; Biopsy; Drug Tolerance; Galactose; Humans; Liver; Liver Cirrhosis; Methotrexate; Psoriasis | 1982 |
Femoxetine clearance in patients with liver cirrhosis.
Topics: Adult; Aged; Antidepressive Agents; Female; Galactose; Humans; Kinetics; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Piperidines | 1984 |
Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival?
Topics: Cardiac Output; Esophageal and Gastric Varices; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Portal System; Portasystemic Shunt, Surgical; Splenorenal Shunt, Surgical | 1983 |
[Caffeine--an ubiquitous indicator of liver function].
Topics: Adult; Aged; Caffeine; Female; Galactose; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Sulfobromophthalein | 1983 |
Splanchnic galactose uptake in patients with cirrhosis following single injection.
Topics: Catheterization; Galactose; Hepatic Veins; Humans; Injections, Intravenous; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Splanchnic Circulation | 1983 |
Splanchnic galactose uptake in patients with cirrhosis during continuous infusion.
Topics: Catheterization; Galactose; Hepatic Veins; Humans; Infusions, Parenteral; Kidney; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Renal Veins; Splanchnic Circulation | 1983 |
Effective liver blood flow: determination by galactose clearance.
Topics: Animals; Dogs; Fluorometry; Galactose; Humans; Kinetics; Liver Circulation; Liver Cirrhosis; Metabolic Clearance Rate | 1983 |
[Tryptophan loading test as a function parameter in liver diseases].
Topics: Adult; Aged; Galactose; Half-Life; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Middle Aged; Sulfobromophthalein; Tryptophan | 1983 |
First-order clearance of plasma galactose: the effect of liver disease.
Topics: Erythrocytes; Galactose; Galactosemias; Hepatitis; Humans; Kidney; Kinetics; Liver; Liver Circulation; Liver Cirrhosis | 1982 |
The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
Topics: Adult; Aged; Female; Galactose; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged; Prognosis | 1982 |
The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
Topics: Adult; Aged; Biopsy, Needle; Body Surface Area; Body Weight; Female; Galactose; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged | 1982 |
Plasma amino acids as markers of liver dysfunction in cirrhotics.
Topics: Adult; Aged; Amino Acids; Ammonia; Female; Galactose; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Methionine; Middle Aged; Phenylalanine; Tryptophan; Tyrosine | 1981 |
Continuous-flow fluorometry of low galactose concentrations in blood or plasma.
Topics: Anticoagulants; Fluorometry; Galactose; Galactosemias; Humans; Liver; Liver Cirrhosis; Regional Blood Flow; Specimen Handling | 1980 |
[Blood clearance of galactose: its clinical interest].
Topics: Galactose; Galactosemias; Humans; Liver Cirrhosis | 1980 |
[Disaccharidase activity and state of carbohydrate absorption in chronic liver diseases].
Topics: Chronic Disease; Disaccharidases; Galactose; Glucose; Hepatitis; Humans; Intestinal Absorption; Liver Cirrhosis | 1980 |
[Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
Topics: Adult; Aged; Biopsy, Needle; Breath Tests; Female; Galactose; Hepatitis C; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; RNA, Viral; Viremia | 1995 |
Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
Topics: Adult; Cefoperazone; Chromatography, High Pressure Liquid; Galactose; Galactosemias; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Metabolic Clearance Rate | 1995 |
The effect of hyperosmotic solutions on the hepatic blood flow.
Topics: Animals; Electromagnetic Phenomena; Galactose; Humans; Hypertonic Solutions; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Mannitol; Osmolar Concentration; Portal Pressure; Rheology; Swine | 1993 |
Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin.
Topics: Adult; Aged; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Carrier Proteins; Female; Galactose; Hepatectomy; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prognosis; Radionuclide Imaging; Receptors, Cell Surface; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 1994 |
Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848).
Topics: Adult; Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Aspartate Aminotransferases; Bilirubin; Blood Pressure; Cholinesterases; Cilazapril; Creatinine; Female; Galactose; Heart Rate; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Reference Values; Renin; Serum Albumin | 1993 |
Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aminopyrine; Blood Volume; Deuterium; Fibrinogen; Galactose; Gas Chromatography-Mass Spectrometry; Hepatitis B; Hepatitis C; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Phenylalanine; Radioisotope Dilution Technique; Serum Albumin | 1996 |
Transamination of methionine after loading in patients with cirrhosis.
Topics: Galactose; Humans; Liver Cirrhosis; Methionine; Sulfhydryl Compounds | 1996 |
Reduced hepatic functional reserve in cirrhosis and obstructive jaundice with special reference to histological morphometric analysis and galactose elimination capacity.
Topics: Adult; Aged; Cholestasis; Female; Galactose; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1996 |
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Galactose; Humans; Hypertension, Portal; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Purines | 1996 |
Uncertainty in liver function assessment on the basis of single-point galactose concentration.
Topics: Analysis of Variance; Biomarkers; Child; Child, Preschool; Chronic Disease; Confidence Intervals; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Time Factors | 1997 |
Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Topics: Adult; Aged; Aminopyrine; Ascites; Breath Tests; Female; Galactose; Humans; Indocyanine Green; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Natriuresis; Reference Values; Regression Analysis; Sorbitol | 1997 |
[13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C.
Topics: Administration, Oral; Biopsy; Breath Tests; Carbon Dioxide; Carbon Isotopes; Female; Galactose; Hepatitis C, Chronic; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1999 |
Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis.
Topics: Adult; Carbon Isotopes; Eating; Female; Galactose; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Intestinal Absorption; Liver; Liver Cirrhosis; Liver Glycogen; Male; Middle Aged; Postprandial Period; Prothrombin Time; Reference Values; Uridine Diphosphate Glucose | 1999 |
Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites.
Topics: Adult; Ascites; Autonomic Nervous System; Blood Pressure; Female; Galactose; Heart Rate; Hemodynamics; Hemoglobins; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Sympathetic Nervous System; Vagus Nerve; Vascular Resistance | 1999 |
Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity.
Topics: Aminopyrine; Biopsy; Breath Tests; Female; Galactose; Hepatitis C, Chronic; Humans; Indocyanine Green; Liver; Liver Cirrhosis; Liver Function Tests; Male; Microsomes, Liver; Middle Aged; Prognosis; Severity of Illness Index; Sorbitol; Ultrasonography | 2001 |
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
Topics: Aged; Breath Tests; Carbon Radioisotopes; Cytochrome P-450 Enzyme System; Female; Galactose; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lidocaine; Liver; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Tumor Necrosis Factor-alpha | 2001 |
Period-amplitude analysis of the electrodencephalogram correlated with liver function in patients with cirrhosis of the liver.
Topics: Adult; Alpha Rhythm; Computers; Electroencephalography; Galactose; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Middle Aged; Periodicity; Portacaval Shunt, Surgical | 1975 |
Heparin elimination in patients with liver cirrhosis.
Topics: Aged; Antithrombin III; Antithrombins; Female; Galactose; Heparin; Humans; Liver; Liver Cirrhosis; Male; Middle Aged | 1977 |
14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aminopyrine; Breath Tests; Carbon Radioisotopes; Chronic Disease; Female; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1978 |
Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.
Topics: Ammonia; Antipyrine; Electroencephalography; Fatty Liver, Alcoholic; Female; Galactose; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Neurologic Examination; Nitrogen; Portacaval Shunt, Surgical | 1978 |
Kinetics of intravenous administered L-phenylalanine in patients with cirrohosis of the liver.
Topics: Adult; Aged; Amino Acids; Female; Galactose; Humans; Kinetics; Liver Cirrhosis; Male; Mathematics; Middle Aged; Phenylalanine; Tyrosine | 1977 |
Measurement of intrahepatic shunted blood flow by ethanol-1-14C method as compared with D-galactose-1-14C method.
Topics: Ethanol; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Neoplasms | 1976 |
Liver volume estimated by ultrasonic scanning before and after portal decompression surgery.
Topics: Adult; Aged; Alcoholism; Autopsy; Biopsy; Esophageal and Gastric Varices; Female; Galactose; Gastrointestinal Hemorrhage; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ultrasonography | 1975 |
Preoperative liver function tests correlated with encephalopathy after porta-caval anastomosis.
Topics: Adult; Age Factors; Aged; Alcoholism; Bilirubin; Brain Diseases; Esophageal and Gastric Varices; Female; Galactose; Gastrointestinal Hemorrhage; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portacaval Shunt, Surgical; Preoperative Care; Prognosis; Prothrombin Time; Serum Albumin | 1975 |
[The value of the intravenous galactose tolerance test and serum vitamin B 12 level in the differential diagnosis and prognosis of liver diseases].
Topics: Acute Disease; Chronic Disease; Diagnosis, Differential; Female; Galactose; Hepatitis; Humans; Liver Cirrhosis; Male; Prognosis; Vitamin B 12 | 1975 |
Radiorespirometric study of carbohydrate metabolism in childhood liver disease.
Topics: Carbon Dioxide; Carbon Radioisotopes; Child; Child, Preschool; Fatty Liver; Galactose; Glucose; Humans; India; Infant; Liver Cirrhosis; Syndrome | 1976 |
Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2.
Topics: Adult; Alcoholism; Carbon Dioxide; Carbon Isotopes; Carbon Radioisotopes; Galactose; Humans; Liver Cirrhosis; Middle Aged | 1976 |
Assessment of liver function using a novel galactose single point method.
Topics: Adult; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Galactose; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged | 1992 |
Defective methionine metabolism in cirrhosis: relation to severity of liver disease.
Topics: Adult; Amino Acids; Ammonia; Bilirubin; Blood Glucose; Female; Galactose; gamma-Globulins; gamma-Glutamyltransferase; Humans; Kinetics; Liver Cirrhosis; Male; Methionine; Middle Aged; Platelet Count; Prothrombin Time; Reference Values; Urea | 1992 |
Hyperuricemia induced by fructose load in liver cirrhosis.
Topics: Adult; Female; Fructose; Galactose; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Uric Acid; Xanthine; Xanthines | 1992 |
[Liver function tests in a clinical comparison].
Topics: Cholinesterases; Factor V; Factor VII; Galactose; Hepatic Encephalopathy; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate; Prealbumin; Prothrombin Time; Reference Values; Serum Albumin | 1992 |
Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity.
Topics: Adult; Aged; Biomarkers; Female; Galactose; Humans; Laminin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Peptide Fragments; Procollagen; Radioimmunoassay; Severity of Illness Index; Sorbitol | 1992 |
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
Topics: Aminopyrine; Breath Tests; Female; Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged; Prognosis; Regression Analysis; Survival Analysis | 1991 |
Prognostic indicators in compensated cirrhosis.
Topics: Actuarial Analysis; Adult; Aged; Analysis of Variance; Esophageal and Gastric Varices; Female; Follow-Up Studies; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Prognosis; Prospective Studies; Regression Analysis; Sex Factors; Survival Rate; Ultrasonography | 1991 |
Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method.
Topics: Adult; Aged; Alanine; Amino Acids; Female; Galactose; Humans; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nitrogen; Urea | 1991 |
[Oral galactose tolerance test in the study of glucose metabolism disorders in patients with liver disease].
Topics: Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 2; Female; Galactose; Galactosemias; Glucose Tolerance Test; Hepatitis; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Time Factors | 1990 |
Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity.
Topics: Adult; Female; Galactose; Humans; Life Expectancy; Liver Cirrhosis; Liver Function Tests; Male; Prognosis; Retrospective Studies; Time Factors | 1990 |
[Quantitative liver function tests--a new trend or sensible measure?].
Topics: Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Prognosis | 1989 |
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.
Topics: Adult; Aged; Female; Follow-Up Studies; Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged; Prognosis | 1989 |
Hepatic drug clearance in chronic liver disease: can we expect to find a universal, quantitative marker of hepatic function?
Topics: Antipyrine; Biomarkers; Galactose; Humans; Indocyanine Green; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate | 1989 |
Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
Topics: Alkaline Phosphatase; Carcinoma, Hepatocellular; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Serum Albumin | 1987 |
Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.
Topics: Albumins; Alkaline Phosphatase; Carcinoma, Hepatocellular; Galactose; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis | 1987 |
[The pituitary in the cirrhotic patient: hormonal data].
Topics: Aged; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Pituitary Hormones, Anterior | 1988 |
[The galactose clearance capacity and values of reverse T3 in liver cirrhosis].
Topics: Adult; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Triiodothyronine, Reverse | 1988 |
[Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
Topics: Adult; Aminopyrine; Breath Tests; Female; Galactose; Humans; Indocyanine Green; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1988 |
Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Galactose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Regression Analysis | 1987 |
Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
Topics: Adult; Aged; Antipyrine; Chronic Disease; Female; Galactose; Galactosemias; Hepatitis; Humans; Indocyanine Green; Liver; Liver Circulation; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Models, Biological | 1988 |
Value of prealbumin plasma levels as liver test.
Topics: Adolescent; Adult; Aged; Galactose; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Middle Aged; Prealbumin | 1987 |
Circadian rhythm of plasma cortisol in cirrhosis of the liver: relationship with liver plasma flow.
Topics: Aged; Circadian Rhythm; Galactose; Humans; Hydrocortisone; Liver Circulation; Liver Cirrhosis; Male; Middle Aged | 1987 |
Pituitary-thyroid and pituitary-testis axes in liver cirrhosis.
Topics: Aged; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Pituitary Hormones, Anterior; Testosterone; Thyroid Hormones | 1987 |
Buspirone pharmacokinetics in patients with cirrhosis.
Topics: Adult; Buspirone; Galactose; Half-Life; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged | 1987 |
Effect of portal vein occlusion on liver blood flow in normal and cirrhotic dogs.
Topics: Animals; Cardiac Output; Dogs; Galactose; Hepatic Artery; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Experimental; Portal Vein | 1986 |
Estimation of the hepatic blood "flow" by galactose plasma clearance in patients with liver disease.
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Galactose; Humans; Liver Circulation; Liver Cirrhosis; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1985 |
Analysis of a differential functional pattern between non-cirrhotic chronic liver disease and hepatic cirrhosis: a multivariate approach.
Topics: Ascites; Biopsy; Cholinesterases; Chronic Disease; Diagnosis, Differential; Esophageal and Gastric Varices; Galactose; gamma-Globulins; Hepatomegaly; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Radionuclide Imaging; Serum Albumin; Splenomegaly; Thymol | 1969 |
[Hereditary fructose intolerance (author's transl)].
Topics: Biopsy; Carbohydrate Metabolism, Inborn Errors; Fatty Liver; Female; Fructose; Galactose; Glucose; Humans; Infant; Liver Cirrhosis | 1971 |
Comparison of the indices of the bromsulphalein test, the serum cholinesterase and the galactose test by hepatic cirrhosis.
Topics: Cholinesterases; Clinical Enzyme Tests; Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Sulfobromophthalein | 1974 |
[Study of hepatic function by galactose and bromosulfophthalein: their reciprocal interference].
Topics: Aged; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Middle Aged; Porphyrias; Sulfobromophthalein | 1967 |
Short-term tolbutamide effect on patients with liver cirrhosis.
Topics: Blood Glucose; Blood Proteins; Fatty Acids, Nonesterified; Galactose; Glucuronates; Half-Life; Hexoses; Humans; Liver; Liver Cirrhosis; Time Factors; Tolbutamide | 1974 |
Demonstration of sialyltransferase deficiency in the serum of a patient with alpha-1-antitrypsin deficiency and hepatic cirrhosis.
Topics: Acid Phosphatase; Alanine Transaminase; Alkaline Phosphatase; alpha 1-Antitrypsin Deficiency; Aspartate Aminotransferases; Blood Proteins; Carbon Radioisotopes; Ceruloplasmin; Child; Densitometry; Electrophoresis, Disc; Electrophoresis, Starch Gel; Female; Galactose; Galactosidases; Glucosidases; Glycoproteins; Humans; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis; Metabolism, Inborn Errors; Microscopy, Electron; Sialic Acids; Transferases; Ultracentrifugation | 1974 |
[Lactulose treatment in 80 cirrhotics: basic considerations and results].
Topics: Adult; Ammonia; Chromatography, Thin Layer; Dietary Proteins; Disaccharides; Escherichia coli; Feces; Female; Fructose; Galactose; Humans; Hydrogen-Ion Concentration; Intestines; Lactobacillus; Lactobacillus acidophilus; Liver Cirrhosis; Male; Middle Aged; Phenols; Proteus | 1972 |
[Value of various modifications of the oral galactose tolerance test as an indicator of liver function].
Topics: Acute Disease; Administration, Oral; Chronic Disease; Fatty Liver; Galactose; Galactosemias; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Methods | 1972 |
[Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
Topics: Adult; Ammonia; Brain Diseases; Female; Fructose; Galactose; Humans; Ketones; Lactose; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Portal System | 1972 |
[Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
Topics: Factor V; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Methods; Sulfobromophthalein | 1972 |
[Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
Topics: Adult; Aged; Ascites; Brain Diseases; Chronic Disease; Disaccharides; Female; Fructose; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Portal System | 1972 |
Studies on galactose tolerance test in patients with liver disease.
Topics: Acute Disease; Chromatography, Gas; Chronic Disease; Diabetes Mellitus; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases | 1972 |
Criteria for assessment of functional impairment in patients with cirrhosis of the liver.
Topics: Adolescent; Adult; Aged; Body Weight; Evaluation Studies as Topic; Female; Galactose; Hepatomegaly; Humans; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Oxygen Consumption; Splanchnic Nerves; Sulfobromophthalein | 1973 |
[Parenchymatous liver functional examination. Contribution of the intravenous galactose clearance test. Study with multidimensional statistical analyses].
Topics: Galactose; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Function Tests | 1973 |
Blood gases and acid-base disturbances of arterial blood in chronic liver disease.
Topics: Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Blood; Carbon Dioxide; Chronic Disease; Galactose; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis; Liver Function Tests; Middle Aged; Oxygen; Partial Pressure; Portacaval Shunt, Surgical | 1973 |
[Oral galactose tolerance test as a liver function test with specific determination using galactose dehydrogenase].
Topics: Adolescent; Adult; Aged; Alcohol Oxidoreductases; Chronic Disease; Clinical Enzyme Tests; Diabetes Mellitus; Fatty Liver; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests; Methods; Middle Aged | 1973 |
Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions.
Topics: Administration, Oral; Adult; Aged; Ethanol; Female; Galactose; Humans; Hyperthyroidism; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pregnancy; Protein Deficiency | 1973 |
Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions.
Topics: Adult; Aged; Alcoholism; Chronic Disease; Diabetes Mellitus; Dietary Proteins; Ethanol; Fatty Liver; Female; Galactose; Humans; Hyperthyroidism; Liver Cirrhosis; Liver Function Tests; Malabsorption Syndromes; Male; Middle Aged; Obesity | 1973 |
The diagnostic value of the inhibitory effect of ethanol on galactose elimination in liver disease.
Topics: Adult; Aged; Alcoholism; Biopsy; Depression, Chemical; Ethanol; Fatty Liver; Female; Galactose; Galactosemias; Half-Life; Humans; Liver; Liver Cirrhosis; Male; Middle Aged | 1973 |
Liver function, age, and portasystemic encephalopathy.
Topics: Adult; Aged; Aging; Bilirubin; Chronic Disease; Female; Galactose; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portacaval Shunt, Surgical; Prothrombin Time; Serum Albumin | 1974 |
A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
Topics: Adult; Alcoholism; Cholangitis; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Fatty Liver; Female; Galactose; Humans; Intestinal Diseases; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Organ Size; Sulfobromophthalein; Time Factors; Transaminases | 1974 |
Hepatic neuropathy. A clinical and electrophysiological study.
Topics: Action Potentials; Adult; Aged; Alcoholism; Biopsy; Chronic Disease; Electric Stimulation; Female; Galactose; Glucose Tolerance Test; Humans; Ischemia; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Neural Conduction; Peripheral Nerves; Portacaval Shunt, Surgical | 1974 |
Plasma half-life of phenylbutazone in patients with impaired liver function.
Topics: Adult; Aged; Female; Galactose; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Time Factors | 1974 |
On the diagnostic and prognostic value of the bromsulphthalein test in patients with hepatic cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Female; Fructose-Bisphosphate Aldolase; Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; Sulfobromophthalein | 1971 |
[Oral galactose tolerance test in liver diseases. Studies on technics and on the evaluation of results].
Topics: Administration, Oral; Chronic Disease; Fatty Liver; Galactose; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests | 1972 |
Substitution of the liver. II. Limitations of the heterologously perfused pig liver.
Topics: Acid-Base Equilibrium; Animals; Bile; Blood Circulation Time; Female; Galactose; Hemodynamics; Hemolysis; Humans; Liver Circulation; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Oxygen Consumption; Perfusion; Swine; Water-Electrolyte Balance | 1972 |
Glycosyltransferases in human blood. II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases.
Topics: Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Cystic Fibrosis; Galactosamine; Galactose; Hepatitis A; Hexosyltransferases; Humans; Liver; Liver Cirrhosis; Liver Diseases; Methods; Oligosaccharides; Transferases | 1972 |
[Modern diagnosis of liver function in the chemical laboratory. I. Disturbances of liver cell integrity and metabolic efficiency].
Topics: Albumins; Ammonia; Blood Coagulation Factors; Cholestasis; Cholinesterases; Chronic Disease; Diagnosis, Differential; Fatty Liver; Galactose; Hepatitis; Hepatitis A; Humans; Iron Isotopes; Jaundice; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms | 1972 |
Physiologic measurement of intrahepatic shunted blood flow by means of D-galactose-1-C14.
Topics: Biopsy; Brachial Artery; Carbon Isotopes; Coloring Agents; Galactose; Hepatic Veins; Hepatitis A; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Liver Neoplasms; Methods; Regional Blood Flow; Saphenous Vein; Vena Cava, Superior; Venous Pressure | 1971 |
[Glucagon-induced hyperglycemia as a measure of liver function].
Topics: Adolescent; Adult; Aged; Blood Glucose; Female; Galactose; Glucagon; Half-Life; Humans; Hyperglycemia; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Serum Albumin | 1971 |
[Examination of intravenous galactose loading test].
Topics: Chronic Disease; Diabetes Mellitus; Galactose; Hepatitis; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests | 1971 |
[Determination and clinical observation of non-esterified fatty acid level by modified Duncombe s colorimetric method].
Topics: Administration, Oral; Colorimetry; Diabetes Mellitus; Fatty Acids, Nonesterified; Galactose; Humans; Liver Cirrhosis; Methods | 1971 |
The intravenous galactose test as indicator in the extent of fibrosis in patients with cirrhosis of the liver.
Topics: Adolescent; Adult; Aged; Bilirubin; Biopsy; Blood Proteins; Diagnosis, Differential; Female; Galactose; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Function Tests; Male; Methods; Middle Aged; Sulfobromophthalein | 1969 |
[From genes to enzymes: galactosemia].
Topics: Blood Glucose; Cataract; Diet Therapy; Galactose; Galactosemias; Humans; Kidney Diseases; Liver Cirrhosis; Liver Function Tests; Proteinuria | 1969 |
The discriminatory ability of a galactose tolerance test and some other tests in the diagnosis of cirrhosis of the liver, hepatitis and biliary obstruction.
Topics: Alanine Transaminase; Alkaline Phosphatase; Biliary Tract Diseases; Bilirubin; Clinical Laboratory Techniques; Diagnosis, Differential; Galactose; Hepatitis; Humans; Injections, Intravenous; Jaundice; Kidney Function Tests; Liver Cirrhosis; Liver Diseases; Methods; Thymol | 1969 |
[Analog computer analysis of the galactose turnever in patients with liver diseases and healthy persons].
Topics: Chronic Disease; Computers, Analog; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Methods | 1969 |
[Carbohydrate metabolism anomalies; galactose metabolism].
Topics: Carbohydrate Metabolism, Inborn Errors; Cataract; Clinical Enzyme Tests; Galactose; Galactosidases; Humans; Liver Cirrhosis; Malabsorption Syndromes | 1969 |
Encephalopathy after portacaval shunting managed with lactulose.
Topics: Aged; Brain Diseases; Disaccharides; Female; Fructose; Galactose; Humans; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Complications | 1970 |
Differences in concentration of galactose in arterial, capillary, and venous blood following a single intravenous injection.
Topics: Adult; Aged; Arteries; Capillaries; Female; Galactose; Galactosemias; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Veins | 1970 |
[Hepatic metabolic clearance with galactose].
Topics: Galactose; Hepatitis; Hepatomegaly; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate | 1970 |
[Liver volume in cirrhosis and its relation to liver blood supply and function].
Topics: Atrophy; Galactose; Hepatomegaly; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Liver Regeneration; Oxygen Consumption; Prognosis | 1970 |
[Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading].
Topics: Biopsy; Female; Galactose; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Function Tests; Male; Serum Albumin; Serum Globulins; Sulfobromophthalein | 1970 |
Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
Topics: Adult; Aged; Biopsy; Brain Diseases; Dietary Proteins; Disaccharides; Electroencephalography; Esophageal and Gastric Varices; Female; Fructose; Galactose; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Complications | 1970 |
[Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
Topics: Galactose; Humans; Liver Cirrhosis; Liver Function Tests; Sulfobromophthalein | 1971 |
[Simultaneous bromsulfalein and galactose loading as a liver function test].
Topics: Colitis, Ulcerative; Galactose; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Sulfobromophthalein | 1971 |
[Galactose elimination capacity, a reliable test for quantitative comprehension of the liver function].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Body Weight; Clinical Enzyme Tests; Galactose; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests | 1971 |
[Arterial blood supply of the liver in portal hypertension and liver cirrhosis].
Topics: Angiography; Galactose; Hepatic Artery; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis | 1971 |
[The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
Topics: Adult; Body Surface Area; Body Weight; Fatty Liver; Female; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male | 1967 |
[Diagnosis of fatty liver].
Topics: Chronic Disease; Fatty Liver; Galactose; Hepatitis; Humans; Liver Cirrhosis; Liver Function Tests | 1967 |
Composition and properties of Tamm and Horsfalls urinary glycoproteins in some diseases.
Topics: Chemistry, Clinical; Galactose; Glucose; Glycoproteins; Hexosamines; Humans; Liver Cirrhosis; Mannose; Nephrotic Syndrome; Neuraminic Acids; Proteinuria; Sucrose | 1967 |
[On the value of galactose tolerance test in the enzymatic determination of blood galactose level].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alcohol Oxidoreductases; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Chronic Disease; Clinical Enzyme Tests; Diabetes Mellitus; Fatty Liver; Female; Galactose; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Male; Peroxidases | 1968 |
[Biologic indications and histobiologic forms of subacute alcoholic hepatitis].
Topics: Alcoholism; Blood Protein Electrophoresis; Chemical and Drug Induced Liver Injury; Fatty Liver; Galactose; Humans; Iodohippuric Acid; Liver Cirrhosis; Liver Function Tests; Sulfobromophthalein | 1968 |
[Cirrhogenic development of subacute alcoholic hepatitis (etiologic, biologic, laparoscopic and histologic observation)].
Topics: Adult; Aged; Alcoholism; Blood Protein Electrophoresis; Chemical and Drug Induced Liver Injury; Cholesterol; Galactose; Humans; Hyperbilirubinemia; Jaundice; Lipids; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Sulfobromophthalein; Time Factors | 1968 |
Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Estrogens; Fatty Acids, Nonesterified; Female; Galactose; Glucose; Glucose Tolerance Test; Growth Hormone; Hepatitis; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged | 1969 |
[Interference of bromosulfalein on the hepatic Tm of galactose (preliminary note)].
Topics: Galactose; Humans; Liver Cirrhosis; Porphyrias; Sulfobromophthalein | 1965 |
An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
Topics: Adult; Cholestasis; Female; Galactose; Hepatitis A; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Sulfobromophthalein | 1966 |
[Changes of protein-bound carbohydrates in blood in liver cirrhosis].
Topics: Blood; Blood Glucose; Hexoses; Humans; Liver Cirrhosis; Polysaccharides; Sweetening Agents | 1955 |
INFLUENCE OF HEXOSE ON DETOXICATION. 2. EFFECT OF HEXOSE LOADS ON BLOOD ALCOHOL LEVELS IN RABBITS.
Topics: Blood Chemical Analysis; Blood Glucose; Ethanol; Fructose; Hexoses; Humans; Liver Cirrhosis; Liver Cirrhosis, Experimental; Metabolism; Rabbits; Research; Sorbitol | 1963 |
Carbohydrate metabolism in ICC.
Topics: Blood Glucose; Carbohydrate Metabolism; Child; Hexoses; Humans; Liver Cirrhosis | 1983 |
Serum glycoproteins in Indian Childhood Cirrhosis.
Topics: Child, Preschool; Fucose; Glycoproteins; Hexoses; Humans; India; Infant; Infant, Newborn; Liver Cirrhosis; Sialic Acids | 1980 |
[Biochemical study of the bile in chronic hepatitis and liver cirrhosis].
Topics: Adolescent; Adult; Aged; Bile; Bile Acids and Salts; Bile Pigments; Cholesterol; DNA; Hepatitis; Hexosamines; Hexoses; Humans; Lipids; Liver Cirrhosis; Middle Aged | 1977 |
[Biochemical indices of the activity of chronic process in the liver].
Topics: Adult; Aged; Chronic Disease; Female; Fucose; Glycoproteins; Hepatitis; Hexoses; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1977 |
Carbohydrate content of human red cell membrane in patients with cirrhosis of the liver.
Topics: Blood Proteins; Carbohydrates; Erythrocyte Membrane; Erythrocytes; Fucose; Hexosamines; Hexoses; Humans; Liver Cirrhosis; Membrane Proteins; Sialic Acids | 1977 |
alpha1-Microglobulin, a new low molecular weight plasma protein.
Topics: Amino Acids; Electrophoresis, Polyacrylamide Gel; Glomerular Filtration Rate; Hexosamines; Hexoses; Humans; Immunoelectrophoresis, Two-Dimensional; Kidney Diseases; Liver Cirrhosis; Molecular Weight; Serum Globulins; Sialic Acids; Uremia | 1976 |
[The serum glycoproteins in alcoholic cirrhosis].
Topics: Alcoholism; Alpha-Globulins; Beta-Globulins; Blood Protein Electrophoresis; gamma-Globulins; Glycoproteins; Hexosamines; Hexoses; Humans; Liver Cirrhosis; Mucoproteins; Neuraminic Acids | 1967 |
Glycoproteins and sulfated glycoproteins isolated from human bile.
Topics: Bile; Biliary Tract Diseases; Chemical Precipitation; Cholelithiasis; Chromatography, Ion Exchange; Dialysis; Electrophoresis; Fucose; Glycoproteins; Glycosaminoglycans; Hepatitis; Hexosamines; Hexoses; Humans; Hydrochloric Acid; Liver Cirrhosis; Papain; Peptides; Solubility; Sulfuric Acids | 1970 |
[Glycosaminoglycans and glycoproteins of the blood serum in viral hepatitis and jaundice of diverse etiology].
Topics: Chemical and Drug Induced Liver Injury; Cholestasis; Fucose; Glycoproteins; Glycosaminoglycans; Hepatitis A; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis | 1973 |
[Changes in the carbohydrate composition of fibrinogen in cases of acquired dysfibrinogenemia].
Topics: Blood Coagulation Disorders; Blood Protein Disorders; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Fibrinogen; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis; Liver Neoplasms; Neuraminic Acids | 1970 |
[Changes of carbohydrate components of blood glycoproteids in chronic hepatitis].
Topics: Biopsy; Carbohydrates; Chronic Disease; Diagnosis, Differential; Glycoproteins; Hepatitis; Hexosamines; Hexoses; Histocytochemistry; Humans; Liver; Liver Cirrhosis; Mucoproteins; Neuraminic Acids | 1972 |
[Pathogenesis of hepatogenic ulcer].
Topics: Animals; Carbon Tetrachloride; Duodenal Ulcer; Gastric Acidity Determination; Gastric Juice; Gastric Mucosa; Gastritis; Hexosamines; Hexoses; Histocytochemistry; Humans; Liver Cirrhosis; Neuraminic Acids; Peptic Ulcer; Rats; Stomach Ulcer; Zollinger-Ellison Syndrome | 1971 |
[Initial drop of serum phosphate in healthy persons and patients with liver diseases following intravenous administration of hexoses and sugar alcohols].
Topics: Alcohols; Fatty Liver; Fructose; Glucose; Hexoses; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Diseases; Phosphates; Sorbitol; Xylose | 1969 |
[Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)].
Topics: Adult; Aged; Ammonia; Brain Diseases; Female; Hexoses; Humans; Liver Cirrhosis; Male; Middle Aged | 1970 |
[Liver and blood protein-carbohydrate].
Topics: Amino Sugars; Blood Proteins; Carbohydrates; Cholecystitis; Fatty Liver; Glycoproteins; Hepatitis; Hexoses; Humans; Hyperbilirubinemia; Liver Cirrhosis; Liver Diseases; Mucoproteins; Neuraminic Acids; Pentoses; Protein Binding | 1970 |